---
title: "Cambridge Acquisition Corp. 1Q 2026: Net income $510.3K, EPS $0.02— 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286547201.md"
description: "Cambridge Acquisition Corp. reported a net income of $510,262 and diluted earnings of $0.02 per Class A ordinary share for Q1 2026. As a blank-check SPAC, it recorded no operating revenue and holds approximately $230M in trust for future business combinations. The company is actively sourcing and negotiating acquisition targets while incurring public company expenses."
datetime: "2026-05-15T10:21:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286547201.md)
  - [en](https://longbridge.com/en/news/286547201.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286547201.md)
---

# Cambridge Acquisition Corp. 1Q 2026: Net income $510.3K, EPS $0.02— 10-Q Summary

Cambridge Acquisition Corp. reported net income of $510262 for the quarter ended March 31, 2026, and diluted earnings of $0.02 per Class A ordinary share. As a blank‑check SPAC, the company recorded no operating revenue for the period and maintained trust assets to support an initial business combination.

**Financial Highlights**

-   Net income: $510,262 for the three months ended March 31, 2026.
-   Diluted EPS: $0.02 diluted net income per Class A Ordinary Share for the three months ended March 31, 2026.
-   Revenue: Not reported for the three months ended March 31, 2026 (company is a blank‑check SPAC; no operating revenues).

**Business Highlights**

-   Business model: Targeting industry‑agnostic business combination opportunities with emphasis on underserved sectors experiencing structural shifts.
-   Liquidity & deal readiness: Approximately $230M held in trust to finance an initial business combination and support post‑merger operations.
-   Operational activity: Completed IPO, separated trading of shares and warrants, and is actively sourcing, diligencing and negotiating acquisition targets.
-   Public company costs: Incurred expected public‑company expenses and advisory fees, with operational spend focused on deal sourcing, due diligence and transaction execution.

Original SEC Filing: Cambridge Acquisition Corp. \[ CAQ \] - 10-Q - May. 14, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CAQUW.US](https://longbridge.com/en/quote/CAQUW.US.md)
- [CAQUU.US](https://longbridge.com/en/quote/CAQUU.US.md)
- [CAQ.US](https://longbridge.com/en/quote/CAQ.US.md)

## Related News & Research

- [Cambridge Investment Research Advisors Inc. Boosts Stake in Applied Materials, Inc. $AMAT](https://longbridge.com/en/news/286734262.md)
- [Advance Auto Parts Reports First Quarter 2026 Results; Reaffirms Full Year 2026 Guidance | AAP Stock News](https://longbridge.com/en/news/287202242.md)
- [Cambridge Investment Research Advisors Inc. Increases Position in GE Vernova Inc. $GEV](https://longbridge.com/en/news/286734254.md)
- [Abbott Laboratories $ABT Shares Purchased by Cambridge Investment Research Advisors Inc.](https://longbridge.com/en/news/286734176.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)